Protein Crystallography in Drug Discovery
edited by R.E. Babine
and S.S. Abdel-Meguid
In Protein Crystallography in Drug Discovery, researchers from academia and from leading pharmaceutical companies present valuable first-hand information on how to obtain the desired protein structures and how to exploit crystallographic data for the drug discovery process.
Covers:
- Crystallography of important target classes such as kinases and proteases
- Structure-based design of protease inhibitors
- Structure-based design of kinase inhibitors
- The ribosome and the proteasome as drug targets
- Recent methodological advances in high-throughput crystallography and microcrystallization
Protein Crystallography in Drug Discovery is an indispensable companion for crystallographers involved in protein structure determination as well as drug developers following the structure-based approach.
Contents
- Molecular Recognition of Nuclear Hormone Receptor-Ligand Complexes
- Kinases
- The Proteasome as a Drug Target
- Antibiotics and the Ribosome
- Structure-Based Design of Cathepsin K Inhibitors
- Structure-Based Design of Potent and Selective Cdk4 Inhibitors
- Crystallization and Analysis of Serine Proteases with Ecotin
- X-ray Crystallography in the Development of Orthogonal Ligand-Receptor Pairs
- Engineering Proteins to Promote Crystallization
- High-throughput Crystallography
- Micro-Crystallization
Subject Index